Crescent Biopharma, Inc. (CBIO)
18.51
+0.58
(+3.23%)
USD |
NASDAQ |
Sep 02, 16:00
18.51
0.00 (0.00%)
After-Hours: 20:00
Crescent Biopharma Shareholders Equity (Quarterly) : 163.26M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 163.26M |
| March 31, 2026 | 183.85M |
| December 31, 2025 | 203.01M |
| September 30, 2025 | 116.64M |
| June 30, 2025 | 139.25M |
| March 31, 2025 | 3.375M |
| December 31, 2024 | 5.314M |
| September 30, 2024 | 11.38M |
| June 30, 2024 | 20.06M |
| March 31, 2024 | 28.91M |
| December 31, 2023 | 38.41M |
| September 30, 2023 | 46.55M |
| June 30, 2023 | 54.80M |
| March 31, 2023 | 62.18M |
| December 31, 2022 | 42.93M |
| September 30, 2022 | 48.12M |
| June 30, 2022 | 55.73M |
| March 31, 2022 | 68.03M |
| December 31, 2021 | 81.60M |
| September 30, 2021 | 96.57M |
| June 30, 2021 | 112.29M |
| March 31, 2021 | 125.12M |
| December 31, 2020 | 128.22M |
| September 30, 2020 | 138.27M |
| June 30, 2020 | 145.75M |
| Date | Value |
|---|---|
| March 31, 2020 | 148.49M |
| December 31, 2019 | 154.20M |
| September 30, 2019 | 167.08M |
| June 30, 2019 | 178.56M |
| March 31, 2019 | 192.79M |
| December 31, 2018 | 205.46M |
| September 30, 2018 | 218.10M |
| June 30, 2018 | 227.99M |
| March 31, 2018 | 238.04M |
| December 31, 2017 | 119.70M |
| September 30, 2017 | 108.56M |
| June 30, 2017 | 115.43M |
| March 31, 2017 | 31.89M |
| December 31, 2016 | 35.30M |
| September 30, 2016 | 41.75M |
| June 30, 2016 | 48.88M |
| March 31, 2016 | 34.77M |
| December 31, 2015 | 40.47M |
| September 30, 2015 | 48.70M |
| June 30, 2015 | 55.22M |
| March 31, 2015 | 44.36M |
| December 31, 2014 | 50.80M |
| September 30, 2014 | 57.71M |
| June 30, 2014 | 63.88M |
| March 31, 2014 | 55.35M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Encompass Health Corp. | 2.598B |
| Myriad Genetics, Inc. | 303.90M |
| BioRestorative Therapies, Inc. | 3.026M |
| U.S. Stem Cell, Inc. | -- |
| Marijuana, Inc. | 13.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 182.76M |
| Total Liabilities (Quarterly) | 19.50M |
| Debt to Equity Ratio | 0.0088 |
| Current Ratio | 9.657 |
| Net Debt Paydown Yield | -0.06% |